1. Home
  2. GASS vs MRK Comparison

GASS vs MRK Comparison

Compare GASS & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GASS
    SELLHOLDBUYas of 18 hours ago
  • MRK
    SELLHOLDBUYas of 18 hours ago
  • Stock Information
  • Founded
  • GASS 2004
  • MRK 2000
  • Country
  • GASS Greece
  • MRK United States
  • Employees
  • GASS N/A
  • MRK N/A
  • Industry
  • GASS Marine Transportation
  • MRK Biotechnology: Pharmaceutical Preparations
  • Sector
  • GASS Consumer Discretionary
  • MRK Health Care
  • Exchange
  • GASS Nasdaq
  • MRK Nasdaq
  • Market Cap
  • GASS N/A
  • MRK 218.2B
  • IPO Year
  • GASS 2005
  • MRK N/A
  • Fundamental
  • Price
  • GASS $5.00
  • MRK $78.93
  • Analyst Decision
  • GASS
  • MRK Buy
  • Analyst Count
  • GASS 0
  • MRK 16
  • Target Price
  • GASS N/A
  • MRK $121.40
  • AVG Volume (30 Days)
  • GASS 93.4K
  • MRK 17.5M
  • Earning Date
  • GASS 05-21-2025
  • MRK 04-24-2025
  • Dividend Yield
  • GASS N/A
  • MRK 4.10%
  • EPS Growth
  • GASS 38.69
  • MRK 4714.29
  • EPS
  • GASS 1.90
  • MRK 6.74
  • Revenue
  • GASS $167,262,185.00
  • MRK $64,168,000,000.00
  • Revenue This Year
  • GASS N/A
  • MRK $2.59
  • Revenue Next Year
  • GASS $3.49
  • MRK $6.51
  • P/E Ratio
  • GASS $2.73
  • MRK $11.71
  • Revenue Growth
  • GASS 16.54
  • MRK 6.74
  • 52 Week Low
  • GASS $4.82
  • MRK $77.54
  • 52 Week High
  • GASS $8.84
  • MRK $134.63
  • Technical
  • Relative Strength Index (RSI)
  • GASS 32.11
  • MRK 22.13
  • Support Level
  • GASS $4.90
  • MRK $85.32
  • Resistance Level
  • GASS $6.00
  • MRK $88.90
  • Average True Range (ATR)
  • GASS 0.20
  • MRK 2.84
  • MACD
  • GASS -0.09
  • MRK -1.23
  • Stochastic Oscillator
  • GASS 9.09
  • MRK 7.89

Stock Price Comparison Chart: GASS vs MRK

GASS
MRK
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0102030405060708090100110120130140GASS VS MRK

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use